Clinical Trials Browser

Phase 4 × Breast Neoplasms × Risedronic Acid × Clear all

NCT00485953 2017-10-13

REBBeCA II

Phase 4 Completed

109 enrolled 11 charts

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00082277 2011-01-26

SABRE

Phase 4 Completed

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis